Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Updated: 6/25/2021

Bone Growth Factors

0%
Topic
Review Topic
0
0
0%
0%
Flashcards
40
N/A
N/A
Questions
11
0
0
0%
0%
Evidence
9
0
0
0%
0%
Videos / Pods
5
Topic
  • SUMMARY
      • Overview of Growth Factors
      • Factor
      • Source
      • Receptor Class
      • Function
      • TGF-B
      • Platelets, bone ECM, cartilage matrix
      • Seronine threonine sulfate
      • Pleiotropic growth factor stimulates undifferentiated mensenchymal cell proliferation 
      • BMP
      • Osteoprogenitor cells, osteoblasts, bone ECM
      • Seronine threonine sulfate
      • Promotes differentiation of mesenchymal cells into chondrocytes and osteoblasts.
      • Promotes differentiation of osteoprogenitors into osteoblasts, influences skeletal pattern formation.
      • FGF
      • Macrophages, mesenchymal cells, chondrocytes, osteoblasts
      • Tyrosine kinase
      • Mitogenic for mesenchymal cells, chondrocytes, and osteoblasts.
      • IGF
      • Bone matrix, osteoblasts, chondrocytes
      • Tyrosine kinase
      • Promotes proliferation and differentiation of osteoprogenitor cells.
      • PDGF
      • Platelets, osteoblasts
      • Tyrosine kinase
      • Mitogen for mesenchymal cells and osteoblasts; macrophage chemotaxis.
  • Bone Morphogenetic Protein (BMP) & SMADs
    • Overview
      • BMPs belong to the TGF-B superfamily
      • BMP 2,4,6, and 7 all exhibit osteoinductive activity
      • BMP 3 does not exhibit osteoinductive activity
      • Mutations in BMP-4 are associated with Fibrodysplasia ossificans progressiva
    • Mechanism
      • osteoinductive
        • leads to bone formation
        • activates mesenchymal cells to transform into osteoblasts and produce bone
        • has been found to increase chondrogenic phenotype and matrix synthesis in intervertebral discs
    • Signaling Pathways and Cellular Targets
      • BMP targets undifferentiated perivascular mesenchymal cells
      • activates a transmembrane serine/threonine kinase receptor that leads to the activation of intracellular signaling molecules called SMADs
        • SMADS are primary intracellular signaling mediators
        • currently eight known SMADs, and the activation of different SMADs within a cell leads to different cellular responses.
    • Clinical applications
      • FDA-approved uses
        • rhBMP-2
          • single-­level ALIF from L2 to ­S1 levels in degenerative disc disease together with the lumbar tapered fusion device (LT Cage; Medtronic)
          • open tibial shaft fractures stabilized with an IM nail and treated within 14 days of the initial injury
        • rhBMP-7
          • as an alternative to autograft in recalcitrant long bone nonunions where use of autograft is unfeasible and alternative treatments have failed
          • as an alternative to autograft in compromised patients (with osteoporosis, smoking or diabetes) requiring revision posterolateral/intertransverse lumbar fusion for whom autologous bone and bone marrow harvest are not feasible or are not expected to promote fusion
      • contraindications
        • pregnancy
        • allergy to bovine type I collagen or recombinant human rhBMP­-2
        • infection
        • tumor
        • skeletal immaturity
  • Transforming Growth Factor-B (TGF-B)
    • Mechanism
      • secreted in a paracrine fashion
      • both osteoblast and osteoclasts synthesize and respond to TGF-B
      • found in fracture hematomas and believed to regulate cartilage and bone formation in fracture callus
      • stimulates production of Type II collagen and proteoglycans by mesenchymal cells.
      • induces osteoblasts to synthesize collagen
    • Signal Pathway & Cellular Targets
      • signal mechanism involves transmembrane serine/threonine kinase receptors
    • Clinical applications
      • TGF-B is used to coat porous coated implants to promote bone ingrowth
  • Insulin-like Growth Factor 1 (IGF-1)
    • Overview
      • IGF-1, formerly known as somatomedin-C, possibly acts by both paracrine and endocrine hormone pathways
      • most abundant growth factor in bone
    • Mechanism
      • the products of the GH-IGF-1 system induce proliferation without maturation of the growth plate and thus induce linear skeletal growth.
      • the action of the thyroid hormone axis is via an active metabolite that enters target cells and signals a nuclear receptor to stimulate both proliferation and maturation of the growth plate. Increased amounts of the active steroid hormone metabolite promote proliferation and maturation of the growth plate
      • IGF-1 may have a role in enhancing bone formation in defects that heal via intramembranous ossification
    • Signal Pathway & Cellular Targets
      • signal mechanism involves tyrosine kinase receptors
  • Insulin-like Growth Factor 2 (IGF-2)
    • Overview
      • more potent than IGF-1
    • Mechanism
      • stimulates type I collagen production
      • stimulates cartilage matrix synthesis
      • stimulates cellular proliferation
      • stimulates bone formation
    • Signal Pathway & Cellular Targets
      • signal mechanism involves tyrosine kinase receptors
  • Fibroblast Growth Factor (FGF)
    • Overview
      • FGF-1 and FGF-2 are most abundant
      • promote growth and differentiation of a variety of cells
        • epithelial cells
        • myocytes
        • osteoblasts
        • chondrocytes
    • Mechanism
      • binds to membrane spanning tyrosine kinase
      • associated with angiogenesis and chondrocyte and osteoblast activation
      • involved in early stages of fracture healing
  • Platelet-derived growth factor (PDGF)
    • Mechanism
      • released from platelets and signals inflammatory cells to migrate to fracture site
      • role in fracture healing and bone repair has not been clearly defined
    • Signal Pathway & Cellular Targets
      • signal mechanism involves tyrosine kinase receptors
  • Peroxisome proliferator-activated receptor gamma (PPAR-gamma or PPARG)
    • Overview
      • key factor demonstrated in adipogenic differentiation of mesenchymal precursor cells in vitro
    • Signal Pathway & Cellular Targets
      • a nuclear binding receptor that binds to DNA and regulates transcription of target genes
    • Clinical and research applications
      • utilized for adipogenic differentiation in vitro
      • agonists are being utilized to attempt treatment of hyperglycemia and hyperlipidemia
      • targeted by thiazolidinediones for treatment of diabetes
Flashcards (40)
Cards
1 of 40
Questions (11)

(SBQ18SP.11) When considering using recombinant human BMP-2 in orthopaedic surgery, all of the following are true EXCEPT:

QID: 211223

It is FDA indicated for acute open tibial shaft fracture

17%

(325/1949)

It is FDA indicated for single level posterolateral lumbar fusions

24%

(467/1949)

It is cost-effective for posterolateral lumbar fusions when compared to iliac crest bone graft

29%

(557/1949)

It is FDA indicated for single level ALIFs

14%

(281/1949)

It has a decreased risk of revision surgery when compared to iliac crest bone grafting in posterolateral lumbar fusions

16%

(304/1949)

L 5 A

Select Answer to see Preferred Response

Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK

(OBQ13.247) BMP is FDA approved for well-defined medical conditions in limited patient populations. In which of the following clinical scenarios is use of rhBMP-2 FDA approved?

QID: 4882

In a 32-year-old male with an acute, open tibial shaft fracture treated with minimally-invasive locked plating 8 days from the initial injury

28%

(930/3309)

In the lumbar spine in a 45-year-old female undergoing posterior decompression and instrumented posterolateral fusion from L4 to S1

14%

(472/3309)

In the cervical spine in a 56-year-old female undergoing anterior cervical discectomy and fusion of C5-C6

3%

(112/3309)

In the lumbar spine in a 52-year-old male undergoing L5-S1 anterior lumbar interbody fusion for degenerative disc disease and spinal stenosis

49%

(1612/3309)

In the cervical spine in a 60-year-old male undergoing posterior decompression and posterior instrumented fusion of C3-C7

5%

(155/3309)

L 5 C

Select Answer to see Preferred Response

Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK

(SBQ12SP.46) Which of the following substances increases the chondrogenic phenotype of intervertebral disk cells and matrix synthesis?

QID: 3744

Osteoprotegrin

19%

(395/2033)

Osteonectin

25%

(510/2033)

Hyperosmotic saline

4%

(82/2033)

Corticosteroids

2%

(50/2033)

Bone morphogenic proteins

48%

(979/2033)

L 4 C

Select Answer to see Preferred Response

(OBQ11.183) Altered BMP-4 signal transduction is known to be associated with which of the following diseases?

QID: 3606

Fibrodysplasia ossificans progressiva

57%

(1744/3049)

Mazabraud's syndrome

5%

(154/3049)

Ollier's syndrome

7%

(224/3049)

Osteopetrosis

22%

(684/3049)

Osteopoikilosis

7%

(223/3049)

L 4 C

Select Answer to see Preferred Response

Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK

(OBQ09.139) All of the following are true of BMP-3 EXCEPT?

QID: 2952

It antagonizes the activity of BMP-2

20%

(433/2150)

It is the most abundant BMP in demineralized bone matrix

15%

(328/2150)

Knockout mice have twice as much trabecular bone as controls

11%

(247/2150)

It is osteoinductive

41%

(881/2150)

It increases levels of chondrogenic markers like Type II collagen and aggregcan

12%

(249/2150)

L 4 D

Select Answer to see Preferred Response

Evidence (9)
VIDEOS & PODCASTS (6)
EXPERT COMMENTS (5)
Private Note